Targeting the early life stages of SARS-CoV-2 using a multi-peptide conjugate vaccine. Myburgh L, Karsjens H, Blanas A, de Ligt A, et al. Vaccine 2025;54:126989.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Myburgh L, Karsjens H, Blanas A, de Ligt A, et al. Targeting the early life stages of SARS-CoV-2 using a multi-peptide conjugate vaccine. Vaccine 2025;54:126989.
PMID: 40088511